Patent · US Expired

Determination of non-functioning areas of the g.i. tract using MRI of manganese composition

US6136292A · kind A · utility

8Cited by
13References
24Claims
0Family size

Assignee

Inventors

Key dates

Filing dateMay 14, 1998
Grant dateOct 24, 2000
Priority date
Expiry dateMay 14, 2018

Classification

  • Technology area (CPC A)Human Necessities
  • CPC primaryA61K49/1887
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

The invention provides a method of functional imaging of a human or non-human animal body, which method comprises administering into the gastrointestinal tract of a said body an effective amount of a composition comprising (a) a first contrast agent comprising a physiologically tolerable manganese compound or a salt thereof, together with (b) a second contrast agent, and generating a functional image of the gastrointestinal tract of said body. This imaging technique has surprisingly been found to provide clear delineation of those portions of the gut wall in which manganese uptake is occurring, thereby enabling not only the detection of tumors in the gut, but also the identification of regions of the gut which may be functioning abnormally.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.